Autologous Tcell gene therapy: CEGE filed an IND to begin a Phase II trial

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: Autologous Tcell gene therapy Indication: HIV Status: CEGE filed an IND to begin a Phase II trial in which the patient's T cells will be genetica...